ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Selexis, Pandion Enter Antibody Service Agreement contractpharma
March 17, 2021Selexis SA, a JSR Life Sciences company, has signed a service agreement with Pandion Therapeutics, Inc. to advance the development of Pandion’s PT627, a systemically-acting PD-1 agonist antibody for the potential treatment of autoimmune and ... -
Merck signs agreement to buy Pandion Therapeutics for $1.85bn pharmaceutical-technology
March 01, 2021Merck has agreed to acquire biotechnology company Pandion Therapeutics for approximately $1.85bn to expand its portfolio of autoimmune disease-targeting candidates.
Pharma Sources Insight January 2025
